Neogen Bundle
Who Really Owns Neogen Corporation?
Understanding the ownership structure of a company is crucial for investors and stakeholders alike. The evolution of Neogen SWOT Analysis, from its inception to its current global presence, is a compelling story of strategic shifts and significant partnerships. This article unveils the key players behind Neogen's success and the forces shaping its future.
The 2022 merger with 3M's food safety business dramatically altered Neogen's landscape, making it essential to examine the current Neogen ownership. This deep dive into Neogen Corporation will explore the impact of this pivotal deal, identifying major shareholders and their influence on the company's strategic direction. Discover the answers to "Who owns Neogen?" and gain valuable insights into this industry leader's financial health and future prospects.
Who Founded Neogen?
The story of Neogen Corporation began in 1982, marking the start of its journey in the biotechnology field. The company was founded in Lansing, Michigan, by Herbert D. 'Ted' Doan and James L. Herbert. Their vision was to create a company focused on solutions for food and animal safety, a mission that has remained central to Neogen's operations since its inception. This early focus set the stage for the company's future growth and development.
The initial funding and support from Michigan State University were critical to Neogen's early success. The university's investment, coupled with the expertise of the founders, helped shape the company's direction. This collaboration between the founders and the university underscores a shared commitment to advancing biotechnology for the benefit of society. The early ownership structure, influenced by the university's backing, provided the necessary capital for Neogen's initial growth.
The Michigan State University Foundation played a vital role in Neogen's early ownership structure. The foundation's initial investment of $50,000 and the awarding of 30% of the company's shares in the early years were crucial. Herbert D. Doan, with his experience as a former CEO at Dow Chemical, and James L. Herbert, brought the vision to life, supported by the university's commitment to fostering the biotechnology community in the region.
Founding Date
Neogen Corporation was founded in 1982.
Founders
Herbert D. 'Ted' Doan and James L. Herbert.
Initial Investment
Michigan State University Foundation provided an initial $50,000 investment.
Early Ownership
Michigan State University Foundation was awarded 30% of the company's shares.
Location
Founded in Lansing, Michigan.
Focus
Solutions for food and animal safety.
Key Takeaways on Neogen Ownership
Understanding the early ownership structure of Neogen, including the roles of the founders and the Michigan State University Foundation, provides insight into the company's initial direction and values. Key aspects of Neogen's history include:
- The founders' vision was to create solutions for food and animal safety.
- Michigan State University provided early financial backing and strategic support.
- The Michigan State University Foundation held a significant share of the company in its early years.
- The company's inception was rooted in commercializing biotechnology from the university.
Neogen SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Neogen’s Ownership Changed Over Time?
The Neogen company profile reveals its journey since going public in 1990. A pivotal moment in the company's history was the September 2022 merger with 3M's food safety business, Garden SpinCo Corporation. This strategic move significantly reshaped the ownership structure of Neogen Corporation.
Post-merger, pre-merger holders of Garden SpinCo common stock held approximately 50.1% of Neogen's common stock, while pre-merger Neogen shareholders held about 49.9% of the outstanding shares. This transaction marked a substantial shift in the company's ownership landscape, integrating a major business segment and its associated shareholder base.
| Shareholder Type | February 2025 | May 2025 |
|---|---|---|
| Institutional Ownership | 123.42% | 125.98% |
| Mutual Funds | 94.76% | 93.86% |
| Insider Ownership | 1.03% | 1.23% |
As of May 2025, institutional investors maintained a strong presence, with ownership reaching 125.98%. Key institutional shareholders include BlackRock, Inc., holding 31,559,156 shares as of March 31, 2025, and Vanguard Group Inc., with 23,550,128 shares on the same date. Other significant holders include William Blair Investment Management, Llc, Baillie Gifford & Co, and Gates Capital Management, Inc. Mutual funds held 93.86% of shares in May 2025. Insider ownership increased slightly to 1.23% in May 2025. These figures highlight the influence of institutional investors on Neogen's ownership and strategic direction.
Key Ownership Insights
The ownership structure of Neogen is heavily influenced by institutional investors.
- Institutional ownership is at 125.98% as of May 2025.
- BlackRock and Vanguard are among the largest institutional shareholders.
- Insider ownership is a small percentage but has increased slightly.
Neogen PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Neogen’s Board?
The current Board of Directors of Neogen Corporation plays a pivotal role in guiding the company's strategy and governance. James C. Borel holds the position of Chairman. As of May 13, 2025, the company announced a board transition, with Andrea Wainer joining, effective June 1, 2025, succeeding James P. Tobin, who retired on May 31, 2025. Ms. Wainer brings over 25 years of experience in the diagnostics and healthcare sector, previously serving as Executive Vice President, Rapid and Molecular Diagnostics at Abbott Laboratories.
The board's composition, including individuals with significant industry experience like Andrea Wainer, can influence decision-making and strategic initiatives. While the specifics of the voting structure aren't detailed, the substantial institutional ownership suggests that major shareholders, such as BlackRock and Vanguard, have considerable voting power due to their significant equity stakes. Understanding the board's structure is crucial for assessing the company's direction and the influence of major stakeholders in Neogen Corporation.
| Board Member | Title | Date Joined |
|---|---|---|
| James C. Borel | Chairman | N/A |
| Andrea Wainer | Director | June 1, 2025 |
| James P. Tobin | Former Director | N/A |
The voting power within Neogen is significantly influenced by its major shareholders. These large institutional investors, including firms like BlackRock and Vanguard, possess considerable voting rights due to their substantial equity holdings. This concentration of ownership means that their decisions can have a considerable impact on the company's strategic direction and governance. The presence of experienced directors, such as Andrea Wainer, also plays a role in shaping the company's future.
Key Takeaways on Neogen's Board and Ownership
The Board of Directors is led by Chairman James C. Borel, with recent changes including the appointment of Andrea Wainer. Major institutional investors hold significant voting power.
- Board transitions can influence strategic decisions.
- Institutional ownership impacts voting power.
- Industry experience on the board is a key factor.
- Understanding the board's structure is vital for assessing the company's direction.
Neogen Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Neogen’s Ownership Landscape?
Over the past few years, the ownership structure of Neogen Corporation has seen significant shifts. A major event was the merger with 3M's food safety business in September 2022, valued at approximately $5.3 billion. Following this merger, former 3M food safety business shareholders held roughly 50.1% of Neogen's common stock, while pre-merger Neogen shareholders owned about 49.9%. This strategic move reshaped the company's ownership landscape, impacting the distribution of shares among its stakeholders.
Recent developments also include leadership changes within the Neogen company profile. In April 2025, John Adent, the CEO and President for eight years, announced his departure, and a special committee was formed to find his successor. Additionally, Doug Jones, the former Chief Operating Officer, retired on February 28, 2025. David Naemura took on the COO role in addition to his CFO responsibilities starting January 1, 2025. Furthermore, the sale of its global cleaners and disinfectants business to Kersia Group for $130 million in cash, effective in the first quarter of fiscal year 2026, is expected to improve margins and reduce the company's net leverage ratio by about 0.4x.
| Ownership Category | Share Count (as of May 2025) | Percentage of Shares |
|---|---|---|
| Institutional Owners | 342,796,363 | Significant Majority |
| Insider Ownership | N/A | 1.23% |
| Major Institutional Investors (e.g., BlackRock, Inc., Vanguard Group Inc.) | Varies (e.g., BlackRock: 31,559,156 shares as of March 31, 2025) | Significant |
Institutional ownership continues to be a dominant trend in Neogen ownership, with 712 institutional owners and shareholders holding a total of 342,796,363 shares as of May 2025. Major institutional investors like BlackRock, Inc. and Vanguard Group Inc. remain significant shareholders. BlackRock held 31,559,156 shares, and Vanguard held 23,550,128 shares as of March 31, 2025. While insider ownership saw a slight increase to 1.23% in May 2025, it remains relatively small compared to institutional holdings. For more insights into the Neogen company profile, you can explore the Growth Strategy of Neogen.
Who Owns Neogen?
The ownership of Neogen is primarily held by institutional investors, with significant holdings by BlackRock and Vanguard. Insider ownership represents a smaller percentage of the total shares.
Neogen Shareholders
Neogen's major shareholders include institutional investors like BlackRock and Vanguard. These entities hold a substantial portion of the company's outstanding shares.
Neogen History
Neogen's history includes a significant merger with 3M's food safety business in 2022, which reshaped its ownership structure. The company has also seen leadership transitions.
Neogen Company Stock Ownership
The stock ownership of Neogen is largely influenced by institutional investors. The company's financial performance and strategic decisions impact its stock ownership dynamics.
Neogen Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Neogen Company?
- What is Competitive Landscape of Neogen Company?
- What is Growth Strategy and Future Prospects of Neogen Company?
- How Does Neogen Company Work?
- What is Sales and Marketing Strategy of Neogen Company?
- What is Brief History of Neogen Company?
- What is Customer Demographics and Target Market of Neogen Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.